Literature DB >> 16685150

Overcoming the stratum corneum: the modulation of skin penetration. A review.

H Trommer1, R H H Neubert.   

Abstract

It is preferred that topically administered drugs act either dermally or transdermally. For that reason they have to penetrate into the deeper skin layers or permeate the skin. The outermost layer of the human skin, the stratum corneum, is responsible for its barrier function. Most topically administered drugs do not have the ability to penetrate the stratum corneum. In these cases modulations of the skin penetration profiles of these drugs and skin barrier manipulations are necessary. A skin penetration enhancement can be achieved either chemically, physically or by use of appropriate formulations. Numerous chemical compounds have been evaluated for penetration-enhancing activity, and different modes of action have been identified for skin penetration enhancement. In addition to chemical methods, skin penetration of drugs can be improved by physical options such as iontophoresis and phonophoresis, as well as by combinations of both chemical and physical methods or by combinations of several physical methods. There are cases where skin penetration of the drug used in the formulation is not the aim of the topical administration. Penetration reducers can be used to prevent chemicals entering the systemic circulation. This article concentrates on the progress made mainly over the last decade by use of chemical penetration enhancers. The different action modes of these substances are explained, including the basic principles of the physical skin penetration enhancement techniques and examples for their application. Copyright 2006 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16685150     DOI: 10.1159/000091978

Source DB:  PubMed          Journal:  Skin Pharmacol Physiol        ISSN: 1660-5527            Impact factor:   3.479


  61 in total

Review 1.  Bioequivalence for topical products--an update.

Authors:  Yogeeta Narkar
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

2.  Peripheral site acetylcholinesterase inhibitors targeting both inflammation and cholinergic dysfunction.

Authors:  Sherri Young; Karine Fabio; Christophe Guillon; Pramod Mohanta; Timothy A Halton; Diane E Heck; Robert A Flowers; Jeffrey D Laskin; Ned D Heindel
Journal:  Bioorg Med Chem Lett       Date:  2010-03-03       Impact factor: 2.823

3.  Magnetophoresis for enhancing transdermal drug delivery: Mechanistic studies and patch design.

Authors:  S Narasimha Murthy; Srinivasa M Sammeta; C Bowers
Journal:  J Control Release       Date:  2010-08-20       Impact factor: 9.776

4.  Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol.

Authors:  Xiao Wu; Kashappa-Goud H Desai; Susan R Mallery; Andrew S Holpuch; Maynard P Phelps; Steven P Schwendeman
Journal:  Mol Pharm       Date:  2012-03-06       Impact factor: 4.939

Review 5.  Absorption of chemicals through compromised skin.

Authors:  Sanja Kezic; J B Nielsen
Journal:  Int Arch Occup Environ Health       Date:  2009-02-24       Impact factor: 3.015

6.  Enhanced transdermal peptide delivery and stability by lipid conjugation: epidermal permeation, stereoselectivity and mechanistic insights.

Authors:  Sarika Namjoshi; Istvan Toth; Joanne T Blanchfield; Nicholas Trotter; Ricardo L Mancera; Heather A E Benson
Journal:  Pharm Res       Date:  2014-05-21       Impact factor: 4.200

7.  [Basics of topical therapy].

Authors:  J Wohlrab
Journal:  Hautarzt       Date:  2014-03       Impact factor: 0.751

Review 8.  Single compartment drug delivery.

Authors:  Michael J Cima; Heejin Lee; Karen Daniel; Laura M Tanenbaum; Aikaterini Mantzavinou; Kevin C Spencer; Qunya Ong; Jay C Sy; John Santini; Carl M Schoellhammer; Daniel Blankschtein; Robert S Langer
Journal:  J Control Release       Date:  2014-05-04       Impact factor: 9.776

9.  Magnetophoresis in combination with chemical enhancers for transdermal drug delivery.

Authors:  Srinivasa M Sammeta; Michael A Repka; S Narasimha Murthy
Journal:  Drug Dev Ind Pharm       Date:  2011-03-30       Impact factor: 3.225

10.  Impact of Cosmetic Lotions on Nanoparticle Penetration through ex vivo C57BL/6 Hairless Mouse and Human Skin: A Comparison Study.

Authors:  Samreen Jatana; Linda M Callahan; Alice P Pentland; Lisa A DeLouise
Journal:  Cosmetics       Date:  2016-02-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.